GlassScriptPhysician profile
David W Freidberg
NPI 1295700128
$12,853.27
in general payments reported to CMS, 2019-2025
47 companies · $2,399 in 2025
The $2,399 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,189 · 2020: $898 · 2021: $1,963 · 2022: $1,519 · 2023: $2,356 · 2024: $2,530 · 2025: $2,399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,018 · Education: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,017.77 |
| Education | $266.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $3,033.06 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Abbvie INC. | $1,548.37 | 2019-2025 | |
| Astellas Pharma US INC | $977.37 | 2019-2025 | Xtandi |
| Allergan, INC. | $613.42 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $607.22 | 2019-2025 | Provenge |
| Sumitomo Pharma America, INC. | $495.90 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $471.23 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $459.77 | 2024-2025 | Adstiladrin |
| Astrazeneca Pharmaceuticals LP | $424.44 | 2019-2024 | Lynparza |
| Accord Healthcare, INC. | $423.14 | 2022-2025 | |
| Antares Pharma, INC. | $316.65 | 2019-2024 | Xyosted, Nocdurna, Tlando |
| Procept Biorobotics Corporation | $304.31 | 2021-2024 | Aquabeam Robotic System, Aquabeam System |
| Bayer Healthcare Pharmaceuticals INC. | $284.97 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $284.84 | 2020-2023 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $211.49 | 2021-2025 | Lynparza, Keytruda, Welireg |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Freidberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.